J7677 - Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram

Medicare Physician Fee Schedule

Source: CMS Medicare Physician & Other Practitioners public use file (national averages). Amounts are averages across providers, not a fee schedule lookup for a specific locality.